GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » 3-Year EPS without NRI Growth Rate

Masimo (Masimo) 3-Year EPS without NRI Growth Rate : -21.20% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Masimo 3-Year EPS without NRI Growth Rate?

Masimo's EPS without NRI for the three months ended in Dec. 2023 was $1.25.

During the past 12 months, Masimo's average EPS without NRI Growth Rate was -19.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -21.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -10.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Masimo was 39.20% per year. The lowest was -42.30% per year. And the median was 7.90% per year.


Competitive Comparison of Masimo's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Masimo's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Masimo's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Masimo's 3-Year EPS without NRI Growth Rate falls into.



Masimo 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Masimo  (NAS:MASI) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Masimo 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Masimo's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Masimo (Masimo) Business Description

Traded in Other Exchanges
Address
52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Executives
Rolf A Classon director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey other: Director by deputization POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani director, officer: CEO and Chairman of the Board 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi officer: SVP, Chief Accounting Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi officer: COO, Consumer Division C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy officer: President, Consumer 1 VIPER WAY, VISTA CA 92081
Adam Mikkelson director C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy officer: EVP BUS DEV C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young officer: EVP & Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan officer: EVP & GENERAL COUNSEL 40 PARKER, IRVINE CA 92618
Craig B Reynolds director 1046 MIDDLEBROOK WAY, KENESAW GA 30144

Masimo (Masimo) Headlines